Design Therapeutics (DSGN) Shares Outstanding (2020 - 2026)

Design Therapeutics' Shares Outstanding history runs 7 years deep, the most recent figure standing at $62.4 million for Q1 2026.

• In Q1 2026, Shares Outstanding rose 9.99% year-over-year to $62.4 million; the TTM figure through Mar 2026 stood at $62.4 million (up 9.99% YoY), while the FY2025 annual figure was $60.4 million, up 6.42% from the prior year.
• Shares Outstanding came in at $62.4 million for Q1 2026 at Design Therapeutics, up from $60.4 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $62.4 million in Q1 2026 to a low of $55.6 million in Q1 2022.
• A 5-year average of $56.9 million and a median of $56.5 million in 2024 frame the typical range for Shares Outstanding.
• Across the five-year window, Shares Outstanding climbed 0.28% in 2023 and rose 9.99% in 2026, its largest moves.
• Design Therapeutics' Shares Outstanding stood at $55.9 million in 2022, then rose by 1.03% to $56.5 million in 2023, then increased by 0.5% to $56.8 million in 2024, then gained by 6.42% to $60.4 million in 2025, then grew by 3.38% to $62.4 million in 2026.
• According to Business Quant data, Shares Outstanding over the past three periods registered $62.4 million, $60.4 million, and $57.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison